<br />
Valve Replacement<br />
Transcatheter Aortic Valve Implantation in the Hybrid Catheterisation<br />
Laboratory – Navigating into the Future<br />
Michael Lauterbach,1 Bruno Sontag1 and Karl Eugen Hauptmann2<br />
1. Consultant Cardiologist; 2. Head of Department, Department of Medicine III, Krankenhaus der Barmherzigen<br />
Brüder Trier, a teaching affiliate of the University Medical Center Mainz<br />
Abstract<br />
Transcatheter aortic valve implantation (TAVI) has emerged as a viable treatment option for high-risk patients with symptomatic, senile<br />
degenerative aortic stenosis. Since the first TAVI in 2002, the technology has evolved tremendously. With the downsizing of the device<br />
delivery catheter profile, vascular access site complications have decreased significantly. Current access routes are transfemoral,<br />
subclavian, transapical and transaortic, with most centres preferring a `transfem<a title="IXR Surgery - Trier article page 1" href="http://viewer.zmags.com/publication/6304936d?page=1"> Valve Replacement Transcatheter Aortic Valve I</a>
<a title="IXR Surgery - Trier article page 2" href="http://viewer.zmags.com/publication/6304936d?page=2"> Valve Replacement the procedure and patien</a>
<a title="IXR Surgery - Trier article page 3" href="http://viewer.zmags.com/publication/6304936d?page=3"> Transcatheter Aortic Valve Implantation in the Hy</a>
<a title="IXR Surgery - Trier article page 4" href="http://viewer.zmags.com/publication/6304936d?page=4"> Valve Replacement Access Route As learned earl</a>
<a title="IXR Surgery - Trier article page 5" href="http://viewer.zmags.com/publication/6304936d?page=5"> Transcatheter Aortic Valve Implantation in the Hy</a>
<a title="IXR Surgery - Trier article page 6" href="http://viewer.zmags.com/publication/6304936d?page=6"> Valve Replacement Figure 2: HeartNavigator – L</a>